Bedel Financial Consulting’s NeoGenomics NEO Stock Holding History

Bedel Financial Consulting’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-700	Closed	-$9K	–	625
2022 Q1	$9K	Hold	700	–	–	﹤0.01%	693
2021 Q4	$24K	Hold	700	–	–	0.01%	531
2021 Q3	$34K	Hold	700	–	–	0.01%	446
2021 Q2	$32K	Hold	700	–	–	0.01%	466
2021 Q1	$34K	Buy	+700	New	+$36.4K	0.01%	432

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Bedel Financial Consulting's NEO Position: Q2 2022 in Review

Bedel Financial Consulting sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 700 shares — an estimated $9K sold.

Bedel Financial Consulting first reported a position in NEO in Q1 2021 and held it in 5 quarters. The position peaked at $34K in Q3 2021. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

Bedel Financial Consulting reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
Bedel Financial Consulting sold 700 NeoGenomics shares in Q2 2022, an estimated $9K.
Bedel Financial Consulting first reported a position in NeoGenomics in Q1 2021 and held it in 5 quarters.
Bedel Financial Consulting's NeoGenomics position peaked at $34K in Q3 2021.
239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.